Grade 3 Meningioma
Oncology
Prevalence
5.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Grade 3 Meningioma?
There are 1 clinical trial targeting Grade 3 Meningioma tracked by BioSniper.
What is the prevalence of Grade 3 Meningioma?
The estimated prevalence of Grade 3 Meningioma is approximately 5.0 per 100,000 population.
Deep-dive into Grade 3 Meningioma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis